A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Children and Adults with Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome
Details
Age
Child to Adult
Eligibility
Frequently relapsing or steroid-dependent idiopathic nephrotic syndrome and older than 18.
Type of Study
Treatment
Locations
Childrens Hospital Colorado
Principal Investigator
Bradley Dixon, MD
Study ID
Protocol Number: 22-1875
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers